Probiotics and prevention of Clostridium difficile infection

被引：30

作者：

Goldstein, E. J. C. ^{[1
,2
]}

Johnson, S. J. ^{[3
]}

Maziade, P. -J. ^{[4
]}

Evans, C. T. ^{[5
,6
,7
]}

Sniffen, J. C. ^{[8
]}

Millette, M. ^{[9
]}

McFarland, L. V. ^{[10
]}

机构：

[1] RM Alden Res Lab, Santa Monica, CA USA

[2] Univ Calif Los Angeles, Sch Med, Los Angeles, CA USA

[3] Loyola Sch Med, Chicago, IL USA

[4] Pierre Le Gardeur Hosp, Terrebonne, PQ, Canada

[5] Northwestern Univ, Dept Prevent Med, Chicago, IL 60611 USA

[6] Northwestern Univ, Ctr Healthcare Studies, Chicago, IL 60611 USA

[7] Edward Hines Jr VA Hosp, Chicago, IL USA

[8] Florida Hosp, Orlando, FL USA

[9] BioK Plus Int Inc, Laval, PQ, Canada

[10] Univ Washington, Dept Med Chem, Seattle, WA 98195 USA

来源：

ANAEROBE | 2017年 / 45卷

关键词：

Probiotic; Bio-K; Saccharomyces boulardii; C; difficile; Lactobacillus rhamnosus GG; Lactobacillus acidophilus CL1285; Lactobacillus casei LBC80R; Lactobacillus rhamnosus CLR2; LACTOBACILLUS-ACIDOPHILUS CL1285; ANTIBIOTIC-ASSOCIATED DIARRHEA; CASEI LBC80R; COST-EFFECTIVENESS; DOUBLE-BLIND; COMBINATION; EPIDEMIOLOGY; INPATIENTS; SURVIVAL; RELAPSE;

D O I：

10.1016/j.anaerobe.2016.12.007

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

The role of probiotics as adjunctive measures in the prevention of Clostridium difficile infection (CDI) has been controversial. However, a growing body of evidence has suggested that they have a role in primary prevention of CDI. Elements of this controversy are reviewed and the proposed mechanisms of action, the value and cost effectiveness of probiotics are addressed with a focus on three agents, Saccharomyces boulardii, Lactobacillus rhamnosus GG and the combination of Lactobacillus acidophilus CL1285, Lactobacillus casei LBC8OR, Lactobacillus rhamnosus CLR2 (Bio-K+). (C) 2016 Elsevier Ltd. All rights reserved.

引用

页码：114 / 119

页数：6

共 50 条

[1] Lactobacilli and bifidobacteria in the prevention of antibiotic-associated diarrhoea and Clostridium difficile diarrhoea in older inpatients (PLACIDE): a randomised, double-blind, placebo-controlled, multicentre trial [J].

Allen, Stephen J. ;

Wareham, Kathie ;

Wang, Duolao ;

Bradley, Caroline ;

Hutchings, Hayley ;

Harris, Wyn ;

Dhar, Anjan ;

Brown, Helga ;

Foden, Alwyn ;

Gravenor, Michael B. ;

Mack, Dietrich .

LANCET, 2013, 382 (9900) :1249-1257

[2]

[Anonymous], 2013, Antibiotic resistance threats in the United States, 2013

[3] Lactobacillus acidophilus CL1285, Lactobacillus casei LBC80R, and Lactobacillus rhamnosus CLR2 (Bio-K+): Characterization, Manufacture, Mechanisms of Action, and Quality Control of a Specific Probiotic Combination for Primary Prevention of Clostridium difficile Infection [J].

Auclair, Julie ;

Frappier, Martin ;

Millette, Mathieu .

CLINICAL INFECTIOUS DISEASES, 2015, 60 :S135-S143

[4] Effect of a fermented milk combining Lactobacillus acidophilus CL1285 and Lactobacillus casei in the prevention of antibiotic-associated diarrhea:: A randomized, double-blind, placebo-controlled trial [J].

Beausoleil, Melanie ;

Fortier, Nadia ;

Guenette, Stephanie ;

L'Ecuyer, Amelie ;

Savoie, Michel ;

Franco, Martin ;

Lachaine, Jean ;

Weiss, Karl .

CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2007, 21 (11) :732-736

[5]

Clarke T.C., 2015, NATL HLTH SYSTEMS RE, V79

[6] Clinical Practice Guidelines for Clostridium difficile Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA) [J].

Cohen, Stuart H. ;

Gerding, Dale N. ;

Johnson, Stuart ;

Kelly, Ciaran P. ;

Loo, Vivian G. ;

McDonald, L. Clifford ;

Pepin, Jacques ;

Wilcox, Mark H. .

INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2010, 31 (05) :431-455

[7] SURVIVAL OF LACTIC-ACID BACTERIA IN THE HUMAN STOMACH AND ADHESION TO INTESTINAL-CELLS [J].

CONWAY, PL ;

GORBACH, SL ;

GOLDIN, BR .

JOURNAL OF DAIRY SCIENCE, 1987, 70 (01) :1-12

[8] European Society of Clinical Microbiology and Infectious Diseases: update of the treatment guidance document for Clostridium difficile infection [J].

Debast, S. B. ;

Bauer, M. P. ;

Kuijper, E. J. .

CLINICAL MICROBIOLOGY AND INFECTION, 2014, 20 :1-26

[9] Risk and Safety of Probiotics [J].

Doron, Shira ;

Snydman, David R. .

CLINICAL INFECTIOUS DISEASES, 2015, 60 :S129-S134

[10] Efficacy of BIO K+CL1285® in the reduction of antibiotic-associated diarrhea a placebo controlled double-blind randomized, multi-center study [J].

Dylewski, Joe ;

Psaradellis, Eliofotisti ;

Sampalis, John .

ARCHIVES OF MEDICAL SCIENCE, 2010, 6 (01) :56-64

← 1 2 3 4 5 →